Literature DB >> 25077806

Cancer-related fatigue, the role of adrenal suppression and steroids: reply to the comments of Eren et al.

Sriram Yennurajalingam1, Eduardo Bruera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25077806     DOI： 10.1007/s00520-014-2360-7

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  5 in total

1.  Palliative management of fatigue at the close of life: "it feels like my body is just worn out".

Authors:  Sriram Yennurajalingam; Eduardo Bruera
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

2.  Cancer-related fatigue: can it be due to adrenal suppression secondary to high-dose steroids used as antiemetic?

Authors:  Orhan Onder Eren; Mehmet Akif Ozturk; Basak Oyan
Journal:  Support Care Cancer       Date:  2014-01-19       Impact factor: 3.603

3.  Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer.

Authors:  Sriram Yennurajalingam; Susan Frisbee-Hume; J Lynn Palmer; Marvin O Delgado-Guay; Janet Bull; Alexandria T Phan; Nizar M Tannir; Jennifer Keating Litton; Akhila Reddy; David Hui; Shalini Dalal; Lisa Massie; Suresh K Reddy; Eduardo Bruera
Journal:  J Clin Oncol       Date:  2013-07-29       Impact factor: 44.544

4.  Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group.

Authors:  G R Della Cuna; A Pellegrini; M Piazzi
Journal:  Eur J Cancer Clin Oncol       Date:  1989-12

5.  Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study.

Authors:  E Bruera; E Roca; L Cedaro; S Carraro; R Chacon
Journal:  Cancer Treat Rep       Date:  1985 Jul-Aug
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.